Skip to main contentSkip to navigation
Sirius Investors

EBOSY Stock: EBOS Group Limited Stock Price, Analysis & Insights

Get live EBOSY stock price $26.00, comprehensive EBOS Group Limited stock analysis, charts, news, and expert forecast. Real-time EBOSY stock data and investment insights.

26.00
0.00%Today
EBOSYEBOS Group Limited • Other OTC • Healthcare
Market Cap
1.33B
Volume
1
52W High
46.64
52W Low
24.13

Loading chart data...

EBOS Group Limited (EBOSY) Overview

EBOS Group Limited (EBOSY) is a publicly traded company in the Healthcare sector , specifically within the Medical - Distribution industry . As of the latest trading session, EBOSY trades at $26.00 with a market capitalization of 1.33B . Over the past 52 weeks, EBOSY has traded between $24.13 and $46.64 , with the current price positioned at approximately 8% of this range . The stock currently ...

Key Takeaways

  • Operates in the Healthcare sector (Medical - Distribution)
  • Market cap: 1.33B
  • Current price: $26.00
  • 52-week range: $24.13 - $46.64
  • P/E ratio: 17.93

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

EBOS Group Limited, established in 1922 and headquartered in Docklands, Australia, operates as a prominent marketer, wholesaler, and distributor of a broad spectrum of healthcare, medical, pharmaceutical, and animal care products. Its operations span...

Company Information

CEO
Adam Luke Hall
Sector
Healthcare
Industry
Medical - Distribution
Employees
5200

Contact Information

Address
737 Bourke Street
Country
AU

Investment Analysis & Business Insights

Healthcare
Medical - Distribution

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 17.9)

Lower volatility stock (Beta: 0.16) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for EBOS Group Limited shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for EBOS Group Limited
  • Investors should consider how EBOS Group Limited fits within their overall portfolio allocation

Market Cap

1.33B

P/E Ratio (TTM)

17.93

Beta

0.16

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.